Company case study
Alcor
Alcor is a non-profit organization that specializes in cryonics, the preservation of individuals at low temperatures with the hope of future revival. It came up on My First Million, hosted by Sam Parr and Shaan Puri, in the episode "25% Of My Portfolio Is One Overvalued Stock, Here's Why" (aired April 22, 2026).
At a glance
| Podcast | My First Million |
|---|---|
| Hosted by | Sam Parr and Shaan Puri |
| Episode | 25% Of My Portfolio Is One Overvalued Stock, Here's Why |
| Aired | April 22, 2026 |
| Revenue and traction | $200,000 to freeze a whole body, $80,000 to freeze just the head. Additionally, clients can pay $100 a year to secure their spot. |
| Category | Physical-Services |
Figures and claims are as told on the episode, summarized from the transcript. Check the date: they describe the company at the time it aired.
What the episode said
25% Of My Portfolio Is One Overvalued Stock, Here's Why · aired April 22, 2026 · hosted by Sam Parr and Shaan Puri
Why it works
Alcor's business model works because it taps into the human desire for immortality and the hope that future advancements in technology may allow for the revival of preserved individuals.
The playbook
Alcor focuses on educating the public about cryonics, providing a clear pricing structure, and emphasizing the scientific basis behind their methods.
Also mentioned
Alcor has frozen approximately 200 individuals and has around 1,500 clients who have signed up for future preservation.
Why this works now (our analysis)
Most people assume cryonics is a fringe concept, yet Alcor benefits from a growing number of individuals seeking long-term medical solutions. The organization effectively taps into this interest by promoting its services through niche forums like r/Immortality, where potential clients discuss their hopes for future medical advancements. Alcor faces significant regulatory hurdles, particularly around the legal definitions of death, which can complicate the preservation process and impact client acquisition.